Advertisement

CardioVascular and Interventional Radiology

, Volume 36, Issue 6, pp 1614–1623 | Cite as

Metallic Stents for Tracheobronchial Pathology Treatment

  • Carolina Serrano
  • Alicia Laborda
  • Juan M. Lozano
  • Hugo Caballero
  • Antonio Sebastián
  • Jorge Lopera
  • Miguel Ángel de Gregorio
Clinical Investigation

Abstract

Purpose

To present the 7-year experience of the treatment of benign and malignant tracheobronchial stenoses using metallic stents.

Patients and Methods

One hundred twenty-three stents were inserted in 86 patients (74 benign and 12 malignant stenoses). Ninety-seven stents were placed in the trachea and 26 in the bronchi. The procedures were performed under fluoroscopic and flexible bronchoscopic guidance with the patient under light sedation. In cases of severe stenotic lesions or obstructions, laser resection was performed before stent placement. Clinical and functional pulmonary data were recorded before and 3 months after the procedure. Follow-up involved clinical data and radiographic techniques at 48 h and at 1-, 3-, 6-, and 12-month intervals.

Results

The technical success was 100 %. Dyspnea disappearance, forced expiratory volume in the first second, and pulmonary functional data improvement was observed in all patients (p < 0.001). Complications were detected in 23 patients (26.7 %). Mean follow-up time was 6.3 ± 1.2 months in patients with malignant lesions and 76.2 ± 2.3 months patients with in benign lesions. By the end of the study, 100 % of patients with malignant pathology and 6.7 % of patients with benign lesions had died.

Conclusion

Endoluminal treatment of tracheobronchial stenosis with metallic stents is a therapeutic alternative in patients who are poor candidates for surgery. In unresectable malignant lesions, the benefit of metallic stenting is unquestionable. In benign lesions, the results are satisfactory, but sometimes other interventions are required to treat complications. New stent technology may improve these results.

Keywords

Tracheal stenosis Metallic stents 

Notes

Acknowledgments

To Prof. Ignacio de Blas from the University of Zaragoza, for his support in the statistiscal study.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Seijo LM, Sterman DH (2001) Interventional pulmonology. N Engl J Med 344:740–749PubMedCrossRefGoogle Scholar
  2. 2.
    Bolliger CT, Mathur PN, Beamis JF et al (2002) ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J 19:356–373PubMedCrossRefGoogle Scholar
  3. 3.
    Noppen M, Stratakos G, Amjadi K et al (2007) Stenting allows weaning and extubation in ventilator or tracheostomy dependency secondary to benign airway disease. Respir Med 101:139–145PubMedCrossRefGoogle Scholar
  4. 4.
    Bolliger CT, Sutedja TG, Strausz J et al (2006) Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Eur Respir J 27(6):1258–1312PubMedCrossRefGoogle Scholar
  5. 5.
    Noppen M, Piérard D, Meysman M et al (1999) Bacterial colonization of central airways after stenting. Am J Respir Crit Care Med 160:672–677PubMedCrossRefGoogle Scholar
  6. 6.
    Murthy S, Gildea TR, Mehta AC (2004) Removal of self-expanding metallic stents: is it possible? Semin Respir Crit Care Med 25:381–385PubMedCrossRefGoogle Scholar
  7. 7.
    Lunn W, Feller-Kopman D, Wahidi M et al (2005) Endoscopic removal of metallic airway stents. Chest 127:2106–2112PubMedCrossRefGoogle Scholar
  8. 8.
    Food and Drug Administration. (2005) FDA public health notification: complications from metallic tracheal stents in patients with benign airway disorders. Notices/PublicHealthNotifications/ucm062115.htm. Available at: http://www.fda.gov/MedicalDevices/Safety/Alertsand. Accessed 06 July 2012
  9. 9.
    Lund ME, Force S (2007) Airway stenting for patients with benign airway disease and the Food and Drug Administration Advisory: a call for restraint. Chest 132:1107–1108PubMedCrossRefGoogle Scholar
  10. 10.
    Husain SA, Finch D et al (2007) Long-term follow-up of ultraflex metallic stents in benign and malignant central airway obstruction. Ann Thorac Surg 83:1251–1256PubMedCrossRefGoogle Scholar
  11. 11.
    Saad CP, Murthy S, Krizmanich G et al (2003) Self-expandable metallic airway stents and flexible bronchoscopy: Long-term outcomes analysis. Chest 124:1993–1999PubMedCrossRefGoogle Scholar
  12. 12.
    Chung FT, Chen HC, Chou CL et al (2011) An outcome analysis of self-expandable metallic stents in central airway obstruction: a cohort study. J Cardiothorac Surg 6:46PubMedCrossRefGoogle Scholar
  13. 13.
    American Thoracic Society (1995) Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152:1107–1136CrossRefGoogle Scholar
  14. 14.
    Crapo RO, Morris AH, Gardner RM (1981) Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 123:659–664PubMedGoogle Scholar
  15. 15.
    Wanger J, Clausen JL, Coates A et al (2005) Standardization of the measurement of lung volumes. Eur Respir J 26:511–512PubMedCrossRefGoogle Scholar
  16. 16.
    Wood DE, Liu YH, Vallieres E et al (2003) Airway stenting for malignant and benign tracheobronchial stenosis. Ann Thorac Surg 76:167–174PubMedCrossRefGoogle Scholar
  17. 17.
    Noppen M, Stratakos G, D’Haese J et al (2005) Removal of covered self-expandable metallic airway stents in benign disorders: indications, technique, and outcomes. Chest 127:482–487PubMedCrossRefGoogle Scholar
  18. 18.
    Schildge J, Hauk H (2001) Successful treatment of benign tracheal stenosis with a silicone stent (Polyflex stent) over 5 years. Pneumologie 55:152–158PubMedCrossRefGoogle Scholar
  19. 19.
    de Gregorio MA, Medrano J, Alfonso ER et al (1997) Current status and clinical experience in the treatment of tracheobronchial stenoses with self-expanding metallic stents. Arch Bronconeumol 33:509–514PubMedGoogle Scholar
  20. 20.
    Rafanan AL, Mehta AC (2000) Stenting of the tracheobronchial tree. Radiol Clin North Am 38:395–408PubMedCrossRefGoogle Scholar
  21. 21.
    Madden BP, Loke TK, Sheth AC (2006) Do expandable metallic airway stents have a role in the management of patients with benign tracheobronchial disease? Ann Thorac Surg 82:274–278PubMedCrossRefGoogle Scholar
  22. 22.
    Gottlieb J, Fuehner T, Dierich M et al (2009) Are metallic stents really safe? a long-term analysis in lung transplant recipients. Eur Respir J 34:1417–1422PubMedCrossRefGoogle Scholar
  23. 23.
    Thornton RH, Gordon RL, Kerlan RK et al (2006) Outcomes of tracheobronchial stent placement for benign disease. Radiology 240:273–282PubMedCrossRefGoogle Scholar
  24. 24.
    Carré P, Rousseau H, Lombart L et al (1994) Balloon dilatation and self-expanding metal Wallstent insertion. For management of bronchostenosis following lung transplantation. The Toulouse Lung Transplantation Group. Chest 105:343–348PubMedCrossRefGoogle Scholar
  25. 25.
    Rousseau H, Dahan M, Lauque D et al (1993) Self-expandable prostheses in the tracheobronchial tree. Radiology 188:199–203PubMedGoogle Scholar
  26. 26.
    Miyazawa T, Yamakido M, Ikeda S et al (2000) Implantation of ultraflex nitinol stents in malignant tracheobronchial stenoses. Chest 118:959–965PubMedCrossRefGoogle Scholar
  27. 27.
    Chung FT, Lin SM, Chou CL et al (2010) Factors leading to obstructive granulation tissue formation after ultraflex stenting in benign tracheal narrowing. Thorac Cardiovasc Surg 58:102–107PubMedCrossRefGoogle Scholar
  28. 28.
    Chung FT, Lin SM, Chen HC et al (2008) Factors leading to tracheobronchial self-expandable metallic stent fracture. J Thorac Cardiovasc Surg 136:1328–1335PubMedCrossRefGoogle Scholar
  29. 29.
    Herrera JM, McNeil KD, Higgins RS et al (2001) Airway complications after lung transplantation: treatment and long-term outcome. Ann Thorac Surg 71:989–993PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2013

Authors and Affiliations

  • Carolina Serrano
    • 1
    • 2
  • Alicia Laborda
    • 2
  • Juan M. Lozano
    • 3
  • Hugo Caballero
    • 4
  • Antonio Sebastián
    • 5
  • Jorge Lopera
    • 6
  • Miguel Ángel de Gregorio
    • 2
    • 7
  1. 1.Surgical Pathology Unit, Animal Pathology DepartmentUniversity of ZaragozaZaragozaSpain
  2. 2.Minimally Invasive Techniques Research Group (GITMI)University of ZaragozaZaragozaSpain
  3. 3.Radiology DepartmentMarly ClinicBogotáColombia
  4. 4.Pulmonology DepartmentMarly ClinicBogotáColombia
  5. 5.Pulmonology DepartmentLozano Blesa Clinical University HospitalZaragozaSpain
  6. 6.Interventional Radiology DeparmentHealth Science CenterSan AntonioUSA
  7. 7.Intervencional Radiology DepartmentLozano Blesa Clinical University HospitalZaragozaSpain

Personalised recommendations